Johnson & Johnson to Fall Short of 10 Million Vaccine Doses Promised by End of February

CBS News reports that Johnson & Johnson (J&J) expects to fall short of its promised 10 million doses of COVID-19 vaccine by the end of February, with less than 4 million to be ready for shipment after a hoped-for emergency use authorization from the U.S. Food and Drug Administration. The company pledged to ship another 25 million by the end of March. "We will have 20 million doses of the vaccine to be made available by the end of March and we're prepared to ship, immediately upon emergency use authorization, nearly 4 million doses of our vaccine," said J&J's Richard Nettles at a House Energy & Commerce Committee hearing on Tuesday. Although J&J's vaccine is simpler to ship and administer than those from Pfizer and Moderna, states could have problems deciding which sites should be prioritized for shots or how to deal with residents hoping to obtain one vaccine over another. Some guidance could be released this weekend after the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meets to discuss J&J's vaccine.